ACi Swiss Healthcare and Life Sciences Investigations Forum
ACi 2026 Swiss Healthcare and Life Sciences Investigations Forum
When innovation meets scrutiny
Thursday 12 November 2026 | Baker McKenzie, Zurich
The Swiss healthcare and life sciences sector is currently navigating a period of significant change, shaped by evolving regulatory expectations, the growing role of artificial intelligence in investigative practice, and the implications of the EU Pharmaceutical Reform package for the Swiss market. This forum will bring together regulators, in-house practitioners and industry specialists to examine these developments and their practical implications for investigations professionals.
Hosted by Baker McKenzie at its Zurich office, the programme will open with a panel session addressing Swiss regulatory developments and their influence on investigation priorities, enforcement of the revised Federal Act on Data Protection (nFADP) within healthcare, and the broader impact of EU pharmaceutical reform on Switzerland.
A particular highlight will be a presentation from Haleon on the organisation’s approach to deploying AI within its investigations function, covering the rationale for adoption, governance and responsible AI policy, workflow integration, and the practical challenges encountered, including those relating to data quality. This session will offer a candid, first-hand account of AI implementation in practice.
The forum will conclude with an interactive session examining the current challenges facing investigations teams in the sector. Drawing on findings from a delegate survey, this discussion will consider what is working well, how performance might be measured through KPIs and KRIs, and where improvements can be made. Delegates will be encouraged to contribute their own perspectives and experience.
For the full agenda, click here.
Who should attend
This forum is designed for corporate investigators, compliance and ethics professionals, legal counsel, and risk management professionals operating within or alongside the healthcare and life sciences sector, in Switzerland and internationally. It will be of particular relevance to those addressing the integration of AI into investigative practice, navigating Swiss data protection enforcement, or seeking to engage with peers facing comparable regulatory and operational pressures.
Why attend
The forum will offer a focused and substantive programme, combining regulatory insight, practitioner experience and a structured opportunity for peer discussion. The day will conclude with a networking reception, providing a further opportunity for delegates to continue discussions and build connections within the sector.
Hosted by
